BR9406034A - Derivados de imidazoloquinoxalinonas como antagonistas de eaa. - Google Patents

Derivados de imidazoloquinoxalinonas como antagonistas de eaa.

Info

Publication number
BR9406034A
BR9406034A BR9406034A BR9406034A BR9406034A BR 9406034 A BR9406034 A BR 9406034A BR 9406034 A BR9406034 A BR 9406034A BR 9406034 A BR9406034 A BR 9406034A BR 9406034 A BR9406034 A BR 9406034A
Authority
BR
Brazil
Prior art keywords
imidazoloquinoxalinone
derivatives
preparation
eaa antagonists
eaa
Prior art date
Application number
BR9406034A
Other languages
English (en)
Inventor
Hans-Joerg Treiber
Berthold Behl
Hans Peter Hofmann
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4329970A external-priority patent/DE4329970A1/de
Application filed by Basf Ag filed Critical Basf Ag
Publication of BR9406034A publication Critical patent/BR9406034A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BR9406034A 1993-03-31 1994-03-19 Derivados de imidazoloquinoxalinonas como antagonistas de eaa. BR9406034A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4310521 1993-03-31
DE4329970A DE4329970A1 (de) 1993-03-31 1993-09-04 Neue Imidazolo-chinoxalinone, ihre Hestellung und Verwendung
PCT/EP1994/000871 WO1994022865A1 (de) 1993-03-31 1994-03-19 Imidazolochinoxalinonderivate als eaa antagonisten

Publications (1)

Publication Number Publication Date
BR9406034A true BR9406034A (pt) 1996-01-02

Family

ID=25924528

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9406034A BR9406034A (pt) 1993-03-31 1994-03-19 Derivados de imidazoloquinoxalinonas como antagonistas de eaa.

Country Status (17)

Country Link
EP (1) EP0691970B1 (pt)
JP (1) JPH08508271A (pt)
CN (1) CN1041928C (pt)
AT (1) ATE173263T1 (pt)
AU (1) AU6428294A (pt)
BR (1) BR9406034A (pt)
CA (1) CA2158167A1 (pt)
CZ (1) CZ246495A3 (pt)
FI (1) FI954614L (pt)
HR (1) HRP940210A2 (pt)
HU (1) HUT73970A (pt)
IL (1) IL109076A (pt)
NO (1) NO953892D0 (pt)
NZ (1) NZ263552A (pt)
PL (1) PL310950A1 (pt)
SI (1) SI9420023A (pt)
WO (1) WO1994022865A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR970701192A (ko) * 1994-02-11 1997-03-17 안네 섹커 헤테로사이클릭 화합물, 및 이의 제조방법 및 용도(Heterocyclic compounds and their preparation and use)
FR2722789B1 (fr) * 1994-07-20 1996-08-23 Rhone Poulenc Rorer Sa Derives d'acide imidazo (1,2-a)indeno(1,2-e) pyrazine-2-carboxylique, leur preparation et les medicaments les contenant
IT1276167B1 (it) * 1995-11-24 1997-10-27 Foscama Biomed Chim Farma Imidazo(1,2-alfa)chinossalin-4-ammine attivi come antagonisti adenosinici,procedimento per la loro preparazione e loro composizioni
FR2743363A1 (fr) * 1996-01-10 1997-07-11 Rhone Poulenc Rorer Sa 5h,10h-imidazo(1,2-a)indeno(1,2-e)pyrazine-a-ones substituees en position 2, leur preparation et les medicaments les contenant
US6271418B1 (en) * 2000-02-22 2001-08-07 Nippon Kayaku Co., Ltd. Process for preparing (hetero) aromatic substituted benzene derivatives
GB0017518D0 (en) * 2000-07-17 2000-08-30 Merck Sharp & Dohme Therapeutic agents
GB0018473D0 (en) * 2000-07-27 2000-09-13 Merck Sharp & Dohme Therapeutic agents
CN100386326C (zh) * 2003-10-22 2008-05-07 中国人民解放军军事医学科学院毒物药物研究所 1-羟甲基咪唑并[1，2-a]喹喔啉化合物及其应用
WO2008072779A1 (ja) * 2006-12-13 2008-06-19 Aska Pharmaceutical Co., Ltd. キノキサリン誘導体
FR2921927B1 (fr) * 2007-10-03 2012-10-12 Univ De Montpellier 1 Imidazo°1,2-a!quinoxalines et derives pour le traitement des cancers

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2043064B (en) * 1979-02-09 1983-04-13 Roussel Lab Ltd Oximidazoquinoxaline derivatives
US5153196A (en) * 1991-06-05 1992-10-06 Eli Lilly And Company Excitatory amino acid receptor antagonists and methods for the use thereof
US5182386A (en) * 1991-08-27 1993-01-26 Neurogen Corporation Certain imidazoquinoxalinones; a new class of gaba brain receptor ligands

Also Published As

Publication number Publication date
FI954614A0 (fi) 1995-09-28
IL109076A (en) 1997-06-10
FI954614A7 (fi) 1995-09-28
JPH08508271A (ja) 1996-09-03
EP0691970A1 (de) 1996-01-17
NZ263552A (en) 1997-06-24
NO953892L (no) 1995-09-29
HUT73970A (en) 1996-10-28
IL109076A0 (en) 1994-06-24
AU6428294A (en) 1994-10-24
HRP940210A2 (en) 1996-12-31
CA2158167A1 (en) 1994-10-13
CN1041928C (zh) 1999-02-03
ATE173263T1 (de) 1998-11-15
CN1120336A (zh) 1996-04-10
HU9502848D0 (en) 1995-11-28
FI954614L (fi) 1995-09-28
SI9420023A (en) 1996-04-30
CZ246495A3 (en) 1996-03-13
NO953892D0 (no) 1995-09-29
WO1994022865A1 (de) 1994-10-13
EP0691970B1 (de) 1998-11-11
PL310950A1 (en) 1996-01-08

Similar Documents

Publication Publication Date Title
BG101715A (bg) Тетрациклени спиросъединения,метод за тяхното получаване и приложението им като 5нт долу 1d рецепторни антагонисти
NO306779B1 (no) Naftalamider, anvendelse derav og farmasöytisk preparat
GR3019450T3 (en) Azaheterocyclylmethyl-chromans as agents for the treatment of diseases of the central nervous system
PL398445A1 (pl) Kompozycje farmaceutyczne zawierające dekstrometorfan i chininę do leczenia zaburzeń neurologicznych
ATE377592T1 (de) Neurotropische substituierte pyrimidine
ES2132105T3 (es) 2-aminometil-cromanos como principios activos en farmacos para el tratamiento de enfermedades del sistema nervioso central.
ATE223399T1 (de) Quinazolin-4-on ampa antagonisten
FI954614A0 (fi) Imidatsolokinoksalinonijohdannaiset EAA-antagonisteina
ATE381533T1 (de) Pharmazeutisch wirksame verbindungen und methoden zu ihrer anwendung
BR9803385A (pt) AtropisÈmeros de 2,3-dissubstituìdo-(5,6)-heteroaril condensado-pirimidin-4-onas.
ES2124861T3 (es) Derivados de aminoacidos y su utilizacion como inhibidores de la encefalinasa.
TR199901385T2 (xx) Piperidin t�revleri.
NO982863L (no) Nye forbindelser med analgetisk effekt
ES2144857T3 (es) Utilizacion de derivados benzonaftalenicos para la fabricacion de medicamentos destinados para el tratamiento de las enfermedades del sistema nervioso.
BR0016168A (pt) Combinações terapêuticas de (s)-2-(benzilaminometil)-2,3,8,9tetrahidro-7h-1,4-dioxi no[2,3 -e]indol-8-ona e neurolépticos para o tratamento ou prevenção de distúrbios psicóticos
PT889044E (pt) Derivados do 5-(heteroaril)alquil-3-oxo-pirido-(1,2-a)benzimidazole-4-carboxamida (pbi) uteis no tratamento de perturbacoes do sistema nervoso central
BR9714184A (pt) Utilização de bonzoillquil-1,2,3,6-tetraidropiridinas
TR200000916T2 (tr) İkameli piperidin türevleri.
IE45454L (en) Cns-active compositions

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal